Table of Contents
Clinical Development Programs for Chronic Idiopathic Urticaria Indication for H1-antihistamines
Outline
Types of Urticaria
Clinical Features of CIU
Clinical Program for CIU Indication
Patients Enrolled in CIU Studies
Patients Enrolled in CIU Studies
Primary Efficacy Variables
Secondary Efficacy Variables
Safety Assessment
Outline
Loratadine Clinical Program
Loratadine Study C87-056
Loratadine Study C87-056
Loratadine Study C86-044
Loratadine Study C86-044
Loratadine Study C88-067
Desloratadine Clinical Program
Cetirizine Clinical Program
Fexofenadine Clinical Program
Prescription Drugs Marketed in the US for the Treatment of Urticaria
OTC Drugs for Urticaria
Concluding Remarks
|
Author: Badrul A. Chowdhury
|